Literature DB >> 13984363

Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms.

G H STOLLERMAN, M RYTEL, J ORTIZ.   

Abstract

A study was made of the nature of the thermolabile plasma factors in human blood which promote the phagocytosis of Group A streptococci in vitro in the presence of optimal amounts of type-specific M antibody. The plasmas of individuals with strong opsonic activity (normal) were compared with those of some individuals whose opsonic activity was consistently weak (deficient). A general relationship was established between encapsulation of streptococci and the opsonic requirement for thermolabile plasma factor(s). Marked differences in phagocytosis of Group A organisms by human bloods were demonstrated with encapsulated strains only. Human bloods deficient in the cofactor required for opsonization of encapsulated streptococci (coopsonin) showed a normal rate of phagocytosis against all other organisms and particles studied. Furthermore, coopsonin-deficient bloods contained normal levels of four components of complement, of properdin, of lysozyme, and of direct bactericidal activity against several species of Gram-negative organisms and of E. coli bacteriophage. The independence of the streptococcal coopsonin from complement was also demonstrated by absorption of plasma with bentonite and with zymosan. Under appropriate conditions, the coopsonin was reduced without significant loss of complement. The data support the concept that the capsule of the streptococcus imposes an opsonic requirement for a plasma factor(s) which is present in varying amounts in human bloods and which appears to be independent of the complement system. The possibility that it is accessory to the latter components has not been excluded.

Entities:  

Keywords:  ANTIBODIES; COMPLEMENT; MURAMIDASE; PHAGOCYTOSIS; PROPERDIN; STREPTOCOCCUS; ZYMOSAN

Mesh:

Substances:

Year:  1963        PMID: 13984363      PMCID: PMC2180439          DOI: 10.1084/jem.117.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  The relationship of M protein and resistance to phagocytosis in the beta hemolytic streptococci.

Authors:  M MORRIS; C V SEASTONE
Journal:  J Bacteriol       Date:  1955-02       Impact factor: 3.490

2.  The properdin system and immunity. XIV. The injection of human properdin into rabbits and the production of antibodies to properdin.

Authors:  C F HINZ; R J WEDGWOOD; E W TODD; L PILLEMER
Journal:  J Immunol       Date:  1960-12       Impact factor: 5.422

3.  Gel filtration: a method for desalting and group separation.

Authors:  J PORATH; P FLODIN
Journal:  Nature       Date:  1959-06-13       Impact factor: 49.962

4.  A study of the mechanism of the anticomplementary activity of gamma-globulin.

Authors:  D M MARCUS
Journal:  J Immunol       Date:  1960-03       Impact factor: 5.422

5.  Effect of treatment of bentonite on serum protein, lipid phosphorus, and cholesterol.

Authors:  E NIKKILA; N OKER-BLOM
Journal:  Ann Med Exp Biol Fenn       Date:  1952

6.  Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro.

Authors:  J G HIRSCH; A B CHURCH
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

7.  The relative importance of the capsule and the M-antigen in determining colony form of group A streptococci.

Authors:  A T WILSON
Journal:  J Exp Med       Date:  1959-03-01       Impact factor: 14.307

8.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

9.  The ability of group A streptococci killed by heat or mercury arc irradiation to resist ingestion by phagocytes.

Authors:  G G WILEY; A T WILSON
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

10.  Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods.

Authors:  G H STOLLERMAN; F S KANTOR; B D GORDON
Journal:  J Exp Med       Date:  1958-10-01       Impact factor: 14.307

View more
  12 in total

1.  Effects of streptococcal cell wall fragments on phagocytosis and tissue culture cells.

Authors:  J M Jones; J H Schwab
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

2.  Intraphagocytic degradation of group A streptococci: electron microsopic studies.

Authors:  E M Ayoub; J G White
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

3.  An M-associated protein antigen (MAP) of group A streptococci.

Authors:  J P Widdowson; W R Maxted; A M Pinney
Journal:  J Hyg (Lond)       Date:  1971-12

Review 4.  Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

Authors:  M S Seelig
Journal:  Bacteriol Rev       Date:  1966-06

5.  Studies on the chemical composition of streptococcal co-opsonin.

Authors:  M W Rytel; R I Lytle; G A Sanders
Journal:  Experientia       Date:  1964-11-15

6.  Capsular Polysaccharide of Group A Streptococcus.

Authors:  Michael R Wessels
Journal:  Microbiol Spectr       Date:  2019-01

7.  Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia.

Authors:  L K Husmann; D L Yung; S K Hollingshead; J R Scott
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

8.  Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.

Authors:  B F Anthony
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

9.  Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages.

Authors:  E Whitnack; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.

Authors:  J B Dale; R G Washburn; M B Marques; M R Wessels
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.